Perfusion patterns of metastatic gastrointestinal stromal tumor lesions under specific molecular therapy
| Autor: | Konstantin Nikolaou, Christoph R. Becker, Frank Berger, Nicole Schinwald, Maximilian F. Reiser, Steven Sourbron, Marcus Schlemmer |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Adult
Male Pathology medicine.medical_specialty Indoles Gastrointestinal Stromal Tumors Perfusion Imaging Antineoplastic Agents Pilot Projects Blood volume Perfusion scanning Piperazines Metastasis Sunitinib medicine Humans Pyrroles Radiology Nuclear Medicine and imaging Molecular Targeted Therapy Stromal tumor Aged Aged 80 and over Volume of distribution GiST business.industry Angiography General Medicine Middle Aged Protein-Tyrosine Kinases medicine.disease Pyrimidines Treatment Outcome Benzamides Imatinib Mesylate Female Radiology Tomography X-Ray Computed business Perfusion medicine.drug |
| Zdroj: | European Journal of Radiology. 77:312-318 |
| ISSN: | 0720-048X |
| Popis: | Rationale and objective The aim of this pilot study was the evaluation of CT perfusion patterns in metastatic GIST lesions under specific molecular therapy with sunitinib or imatinib both in responders and non-responders. Patients and methods 24 patients with metastatic GIST under tyrosine kinase inhibition were retrospectively evaluated. A total of 46 perfusion and venous phase CT scans were acquired. Volume of distribution, blood flow, blood volume, permeability and hepatic perfusion index measurements of metastatic lesions were carried out. Lesions were classified as "good response" or "poor response" to therapy, and perfusion parameters were compared for these two types of lesions. Results 24 patients were evaluated. In the extrahepatic abdominal lesions ( N =15), good responders showed significant lower perfusion values than poor responders (volume of distribution: 3.3±2.0 vs. 13.0±1.8ml/100ml, p =0.001). The same tendency was observed in intrahepatic lesions ( N =31) (liver volume of distribution: 2.1±0.3 vs. 7.1±1.3ml/100ml, p =0.003); (hepatic perfusion index: 24.3±7.9 vs. 76.1±1.5%, p =0.0001). Conclusion Our data indicate that there are characteristic perfusion patterns of metastatic GIST lesions showing a good or poor response to molecular pharmacotherapy. Perfusion should be further evaluated in cross-sectional imaging studies as a possible biomarker for treatment response in targeted therapies of GIST. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect